Investment efficiency of new drug R&D enhanced by out-sourcing
Published: 1999-09-21 16:32:00
Updated: 1999-09-21 16:32:00
The commercialization of the first domestic new drug strongly motivated local pharmaceutical industry to seek enhancement of efficiency in new drug R&D investment by means of utilizing the third party resource in their R&D process.
The local drug company should upgrade their R&D investment eff...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
